Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1985-04-26
1988-07-05
Gron, Teddy S.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
530387, 4351722, 435 68, 424 85, 424 87, C12N 500, A61L 3940
Patent
active
H00004944
ABSTRACT:
Serotype-specific murine anti-Pseudomonas monoclonal antibodies which bind to determinants of the cell wall lipopolysaccharides of P. aeruginosa are prepared from hybrid cell lines. The antibodies may be of any isotype. These antibodies may be used to treat infections caused by P. aeruginosa.
REFERENCES:
Cryz et al., Inf. Imm. (1983) 40:659-664.
Moody et al., Infect. Imm. (1978) 21:905-913.
Kohler and White, J. Infect. Dis. (1977) 136:112-116.
Collins et al., J. of Trauma (1983) 23: 530-534.
Cryz et al., Infect. Immun. (1983) 39: 1072-1079.
Sawada et al., J. Infect. Dis. (1984) 150: 570-576.
Hancock et al., Infect. Immun. (1982) 37: 166-171.
Mackie et al., J. Immunol. (1982) 129: 829-32.
Cetus Corporation
Gron Teddy S.
Halluin Albert P.
Hasak Janet E.
LandOfFree
Pseudomonas aeruginosa type-specific murine monoclonal antibodie does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pseudomonas aeruginosa type-specific murine monoclonal antibodie, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pseudomonas aeruginosa type-specific murine monoclonal antibodie will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2324674